Gallo JM - Search Results

1

Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance.

Ma J, Murphy M, O'Dwyer PJ, Berman E, Reed K, Gallo JM. Ma J, et al. Among authors: gallo jm. Biochem Pharmacol. 2002 Apr 1;63(7):1219-28. doi: 10.1016/s0006-2952(02)00876-6. Biochem Pharmacol. 2002. PMID: 11960598

2

Time-dependent pharmacodynamic models in cancer chemotherapy: population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine (BSO) in a Phase I trial of melphalan and BSO.

Gallo JM, Brennan J, Hamilton TC, Halbherr T, Laub PB, Ozols RF, O'Dwyer PJ. Gallo JM, et al. Cancer Res. 1995 Oct 15;55(20):4507-11. Cancer Res. 1995. PMID: 7553617 Clinical Trial.

3

High-performance liquid chromatographic method for the determination of AG-331, a novel anti-cancer agent, in human serum and urine using solid-phase extraction and photodiode-array detection.

Qian M, O'Dwyer PJ, Gallo JM. Qian M, et al. Among authors: gallo jm. J Chromatogr B Biomed Appl. 1995 Apr 21;666(2):307-14. doi: 10.1016/0378-4347(94)00589-w. J Chromatogr B Biomed Appl. 1995. PMID: 7633607 Clinical Trial.

4

Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.

O'Dwyer PJ, Hamilton TC, LaCreta FP, Gallo JM, Kilpatrick D, Halbherr T, Brennan J, Bookman MA, Hoffman J, Young RC, Comis RL, Ozols RF. O'Dwyer PJ, et al. Among authors: gallo jm. J Clin Oncol. 1996 Jan;14(1):249-56. doi: 10.1200/JCO.1996.14.1.249. J Clin Oncol. 1996. PMID: 8558205 Clinical Trial.

5

Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470.

Devineni D, Klein-Szanto A, Gallo JM. Devineni D, et al. Among authors: gallo jm. Cancer Res. 1996 May 1;56(9):1983-7. Cancer Res. 1996. PMID: 8616836

6

Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.

O'Dwyer PJ, Szarka CE, Yao KS, Halbherr TC, Pfeiffer GR, Green F, Gallo JM, Brennan J, Frucht H, Goosenberg EB, Hamilton TC, Litwin S, Balshem AM, Engstrom PF, Clapper ML. O'Dwyer PJ, et al. Among authors: gallo jm. J Clin Invest. 1996 Sep 1;98(5):1210-7. doi: 10.1172/JCI118904. J Clin Invest. 1996. PMID: 8787684 Free PMC article. Clinical Trial.

7

In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats.

Devineni D, Klein-Szanto A, Gallo JM. Devineni D, et al. Among authors: gallo jm. Cancer Chemother Pharmacol. 1996;38(6):499-507. doi: 10.1007/s002800050518. Cancer Chemother Pharmacol. 1996. PMID: 8823490

8

Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusion.

O'Dwyer PJ, Laub PB, DeMaria D, Qian M, Reilly D, Giantonio B, Johnston AL, Wu EY, Bauman L, Clendeninn NJ, Gallo JM. O'Dwyer PJ, et al. Among authors: gallo jm. Clin Cancer Res. 1996 Oct;2(10):1685-92. Clin Cancer Res. 1996. PMID: 9816117 Clinical Trial.

9

Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxel.

Obasaju CK, Johnson SW, Rogatko A, Kilpatrick D, Brennan JM, Hamilton TC, Ozols RF, O'Dwyer PJ, Gallo JM. Obasaju CK, et al. Among authors: gallo jm. Clin Cancer Res. 1996 Mar;2(3):549-52. Clin Cancer Res. 1996. PMID: 9816202 Clinical Trial.

10

Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor.

Ma J, Fei ZL, Klein-Szanto A, Gallo JM. Ma J, et al. Among authors: gallo jm. Clin Exp Metastasis. 1998 Aug;16(6):559-68. doi: 10.1023/a:1006598419541. Clin Exp Metastasis. 1998. PMID: 9872603

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

237 results

Search Page